Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGER | Q15109 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23031884 | 0.85 | RAB9A (0.35) | IDO1NPC1GAARAB9AL3MBTL1 | |
| SCHEMBL23031883 | 0.81 | KDM4E (0.31) | MAPT | |
| SCHEMBL23031885 | 0.79 | — | — | |
| SCHEMBL23031871 | 0.72 | RAB9A (0.48) | MAPTMEN1NPC1GAARAB9A | |
| SCHEMBL23032086 | 0.72 | IDO1 (0.32) | AGERIDO1 | |
| SCHEMBL23031763 | 0.69 | IDO1 (0.38) | AGERIDO1 | |
| SCHEMBL23031761 | 0.68 | IDO1 (0.36) | AGERMAPTIDO1 | |
| SCHEMBL10458623 | 0.63 | IDO1 (0.50) | IDO1 | |
| SCHEMBL23031868 | 0.62 | IDO1 (0.42) | AGERIDO1MEN1NPC1RAB9A | |
| SCHEMBL649020 | 0.62 | IDO1 (0.64) | IDO1NPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021034924-A1 | TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO LABELED TETRAZINE AND METHODS | BIOGEN MA INC. (US) | 2021-02-25 | — | — | WO | disclosed |